Jose Antonio Condado

Safety and efficacy of low-dose paclitaxel utilizing the cobra-P drug-eluting stent system with a novel biodegradable coating in de novo coronary lesions: the PLUS-ONE first-in-man study.

P. Fitzgerald, A. Mueller, K. Waseda, 2014, Cardiovascular revascularization medicine : including molecular interventions.